Iranian Journal of Pediatrics

Published by: Kowsar

Detection of Risk Factor Interactions in Cerebral Palsy Using Statistical Methods

Enayatollah Bakhshi 1 , Sepideh Zare Delavar 1 , Farin Soleimani 2 and Akbar Biglarian 1 , *
Authors Information
1 Department of Biostatistics, Social Determinants of Health Research Center, University of Social Welfare and Rehabilitation Sciences, Tehran, Iran
2 Pediatric Neurorehabilitation Research Center, University of Social Welfare and Rehabilitation Sciences, Tehran, Iran
Article information
  • Iranian Journal of Pediatrics: June 2018, 28 (3); e57202
  • Published Online: June 1, 2018
  • Article Type: Research Article
  • Received: July 1, 2017
  • Revised: February 13, 2018
  • Accepted: February 23, 2018
  • DOI: 10.5812/ijp.57202

To Cite: Bakhshi E, Zare Delavar S, Soleimani F, Biglarian A. Detection of Risk Factor Interactions in Cerebral Palsy Using Statistical Methods, Iran J Pediatr. 2018 ; 28(3):e57202. doi: 10.5812/ijp.57202.

Copyright © 2018, Iranian Journal of Pediatrics. This is an open-access article distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 International License ( which permits copy and redistribute the material just in noncommercial usages, provided the original work is properly cited
1. Background
2. Methods
3. Results
4. Discussion
  • 1. Tollanes MC, Wilcox AJ, Lie RT, Moster D. Familial risk of cerebral palsy: population based cohort study. BMJ. 2014;349:g4294. doi: 10.1136/bmj.g4294. [PubMed: 25028249]. [PubMed Central: PMC4099475].
  • 2. Rackauskaite G, Uldall PW, Bech BH, Ostergaard JR. Impact of child and family characteristics on cerebral palsy treatment. Dev Med Child Neurol. 2015;57(10):948-54. doi: 10.1111/dmcn.12791. [PubMed: 25952577].
  • 3. Doyle LW, Crowther CA, Middleton P, Marret S. Antenatal magnesium sulfate and neurologic outcome in preterm infants: a systematic review. Obstet Gynecol. 2009;113(6):1327-33. doi: 10.1097/AOG.0b013e3181a60495. [PubMed: 19461430].
  • 4. Soleimani F, Vameghi R, Biglarian A. Antenatal and intrapartum risk factors for cerebral palsy in term and near-term newborns. Arch Iran Med. 2013;16(4):213-6. [PubMed: 23496363].
  • 5. Soleimani F, Vameghi R, Biglarian A, Daneshmandan N. Risk factors associated with cerebral palsy in children born in Eastern and Northern districts of Tehran. Iran Red Crescent Med J. 2010;12(4):428-33.
  • 6. Paneth N, Hong T, Korzeniewski S. The descriptive epidemiology of cerebral palsy. Clin Perinatol. 2006;33(2):251-67. doi: 10.1016/j.clp.2006.03.011. [PubMed: 16765723].
  • 7. Blair E, Watson L. Epidemiology of cerebral palsy. Semin Fetal Neonatal Med. 2006;11(2):117-25. doi: 10.1016/j.siny.2005.10.010. [PubMed: 16338186].
  • 8. Vincer MJ, Allen AC, Allen VM, Baskett TF, O'Connell CM. Trends in the prevalence of cerebral palsy among very preterm infants (<31 weeks' gestational age). Paediatr Child Health. 2014;19(4):185-9. doi: 10.1093/pch/19.4.185. [PubMed: 24855414]. [PubMed Central: PMC4028643].
  • 9. Iida K, Takashima S, Takeuchi Y, Ohno T, Ueda K. Neuropathologic study of newborns with prenatal-onset leukomalacia. Pediatr Neurol. 1993;9(1):45-8. doi: 10.1016/0887-8994(93)90009-2. [PubMed: 8452600].
  • 10. Nelson KB. Causative factors in cerebral palsy. Clin Obstet Gynecol. 2008;51(4):749-62. doi: 10.1097/GRF.0b013e318187087c. [PubMed: 18981800].
  • 11. Moster D, Lie RT, Markestad T. Long-term medical and social consequences of preterm birth. N Engl J Med. 2008;359(3):262-73. doi: 10.1056/NEJMoa0706475. [PubMed: 18635431].
  • 12. McIntyre S, Taitz D, Keogh J, Goldsmith S, Badawi N, Blair E. A systematic review of risk factors for cerebral palsy in children born at term in developed countries. Dev Med Child Neurol. 2013;55(6):499-508. doi: 10.1111/dmcn.12017. [PubMed: 23181910].
  • 13. Park MY, Hastie T. Penalized logistic regression for detecting gene interactions. Biostatistics. 2008;9(1):30-50. doi: 10.1093/biostatistics/kxm010. [PubMed: 17429103].
  • 14. Ruczinski I, Kooperberg C, LeBlanc M. Logic regression. J Comput Graph Stat. 2003;12(3):475-511. doi: 10.1198/1061860032238.
  • 15. Breiman L, Friedman JH, Olshen RA, Stone CI. Classification and regression trees. Belmont, Calif: Wadsworth; 1984.
  • 16. Ritchie MD, Hahn LW, Roodi N, Bailey LR, Dupont WD, Parl FF, et al. Multifactor-dimensionality reduction reveals high-order interactions among estrogen-metabolism genes in sporadic breast cancer. Am J Hum Genet. 2001;69(1):138-47. doi: 10.1086/321276. [PubMed: 11404819]. [PubMed Central: PMC1226028].
  • 17. He H, Oetting WS, Brott MJ, Basu S. Power of multifactor dimensionality reduction and penalized logistic regression for detecting gene-gene interaction in a case-control study. BMC Med Genet. 2009;10:127. doi: 10.1186/1471-2350-10-127. [PubMed: 19961594]. [PubMed Central: PMC2800840].
  • 18. Sun H, Wang S. Penalized logistic regression for high-dimensional DNA methylation data with case-control studies. Bioinformatics. 2012;28(10):1368-75. doi: 10.1093/bioinformatics/bts145. [PubMed: 22467913]. [PubMed Central: PMC3348559].
  • 19. Moore JH, Gilbert JC, Tsai CT, Chiang FT, Holden T, Barney N, et al. A flexible computational framework for detecting, characterizing, and interpreting statistical patterns of epistasis in genetic studies of human disease susceptibility. J Theor Biol. 2006;241(2):252-61. doi: 10.1016/j.jtbi.2005.11.036. [PubMed: 16457852].
  • 20. Motsinger AA, Ritchie MD. The effect of reduction in cross-validation intervals on the performance of multifactor dimensionality reduction. Genet Epidemiol. 2006;30(6):546-55. doi: 10.1002/gepi.20166. [PubMed: 16800004].
  • 21. Velez DR, White BC, Motsinger AA, Bush WS, Ritchie MD, Williams SM, et al. A balanced accuracy function for epistasis modeling in imbalanced datasets using multifactor dimensionality reduction. Genet Epidemiol. 2007;31(4):306-15. doi: 10.1002/gepi.20211. [PubMed: 17323372].
  • 22. Schwender H, Ickstadt K. Identification of SNP interactions using logic regression. Biostatistics. 2008;9(1):187-98. doi: 10.1093/biostatistics/kxm024. [PubMed: 17578898].
  • 23. Stoknes M, Andersen GL, Elkamil AI, Irgens LM, Skranes J, Salvesen KA, et al. The effects of multiple pre- and perinatal risk factors on the occurrence of cerebral palsy. A Norwegian register based study. Eur J Paediatr Neurol. 2012;16(1):56-63. doi: 10.1016/j.ejpn.2011.10.004. [PubMed: 22104566].
  • 24. O'Callaghan ME, Maclennan AH, Gibson CS, McMichael GL, Haan EA, Broadbent JL, et al. Fetal and maternal candidate single nucleotide polymorphism associations with cerebral palsy: a case-control study. Pediatrics. 2012;129(2):e414-23. doi: 10.1542/peds.2011-0739. [PubMed: 22291124].
  • 25. Gao J, Zhao B, He L, Sun M, Yu X, Wang L. Risk of cerebral palsy in Chinese children: A N:M matched case control study. J Paediatr Child Health. 2017;53(5):464-9. doi: 10.1111/jpc.13479. [PubMed: 28134474].
  • 26. Erkin G, Delialioglu SU, Ozel S, Culha C, Sirzai H. Risk factors and clinical profiles in Turkish children with cerebral palsy: analysis of 625 cases. Int J Rehabil Res. 2008;31(1):89-91. doi: 10.1097/MRR.0b013e3282f45225. [PubMed: 18277211].
  • 27. Masri A, Hamamy H, Khreisat A. Profile of developmental delay in children under five years of age in a highly consanguineous community: a hospital-based study--Jordan. Brain Dev. 2011;33(10):810-5. doi: 10.1016/j.braindev.2010.12.002. [PubMed: 21194858].
  • 28. Hamamy H, Antonarakis SE, Cavalli-Sforza LL, Temtamy S, Romeo G, Kate LP, et al. Consanguineous marriages, pearls and perils: Geneva International Consanguinity Workshop Report. Genet Med. 2011;13(9):841-7. doi: 10.1097/GIM.0b013e318217477f. [PubMed: 21555946].
  • 29. Daher S, El-Khairy L. Association of cerebral palsy with consanguineous parents and other risk factors in a Palestinian population. East Mediterr Health J. 2014;20(7):459-68. doi: 10.26719/2014.20.7.459. [PubMed: 25023773].
  • 30. Abu-Rabia S, Maroun L. The effect of consanguineous marriage on reading disability in the Arab community. Dyslexia. 2005;11(1):1-21. doi: 10.1002/dys.271. [PubMed: 15747804].
  • 31. Othman H, Saadat M. Prevalence of consanguineous marriages in Syria. J Biosoc Sci. 2009;41(5):685-92. doi: 10.1017/S0021932009003411. [PubMed: 19433003].
  • 32. Motsinger AA, Ritchie MD. Multifactor dimensionality reduction: an analysis strategy for modelling and detecting gene-gene interactions in human genetics and pharmacogenomics studies. Hum Genomics. 2006;2(5):318-28. [PubMed: 16595076]. [PubMed Central: PMC3500181].
  • 33. Lee S, Kim Y, Kwon MS, Park T. A Comparative Study on Multifactor Dimensionality Reduction Methods for Detecting Gene-Gene Interactions with the Survival Phenotype. Biomed Res Int. 2015;2015:671859. doi: 10.1155/2015/671859. [PubMed: 26339630]. [PubMed Central: PMC4538337].

Featured Image:

Creative Commons License Except where otherwise noted, this work is licensed under Creative Commons Attribution Non Commercial 4.0 International License .

Search Relations:



Create Citiation Alert
via Google Reader

Readers' Comments